Last 12 months
Inside the activity.
0 purchase rows · 13 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 8 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 2 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 14, 2022 Filed Feb 15, 2022 16:39 UTC |
Weening MichaelPresident & COO
|
GrantCommon Stock | 110 | $38.30 | $4,213.00 |
DisclosureSEC source: 0001628280-22-002723 · wf-form4_164496111778822.xml · nonDerivative · entry 1 Weening Michael · CIK 0001678385 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,032 F1 · shares: The reporting person is voluntarily reporting the acquisition of shares of the issuer's common stock pursuant to the Calix, Inc. Amended and Restated Employee Stock Purchase Plan ("ESPP") for the ESPP purchase period of August 15, 2021 through February 14, 2022. This transaction is exempt under Rule 16b-3(c). F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on August 15, 2022, the first trading day of the purchase period. Read SEC document |
| February 14, 2022 Filed Feb 15, 2022 21:37 UTC |
SINDELAR CORYChief Financial Officer
|
GrantCommon Stock | 478 | $38.30 | $18,307.40 |
DisclosureSEC source: 0001628280-22-002721 · wf-form4_164496105149636.xml · nonDerivative · entry 1 SINDELAR CORY · CIK 0001226868 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,788 F1 · shares: The reporting person is voluntarily reporting the acquisition of shares of the issuer's common stock pursuant to the Calix, Inc. Amended and Restated Employee Stock Purchase Plan ("ESPP") for the ESPP purchase period of August 15, 2021 through February 14, 2022. This transaction is exempt under Rule 16b-3(c). F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on August 15, 2022, the first trading day of the purchase period. Read SEC document |
| February 10, 2022 Filed Feb 11, 2022 16:17 UTC |
Eleniak Shane Todd MarshallEVP, Products
|
GrantStock Option (right to buy) · Derivative | 125,000 | $0.00 Strike: $55.96 | $0.00 |
DisclosureSEC source: 0001628280-22-002334 · wf-form4_164461424050891.xml · derivative · entry 2 Eleniak Shane Todd Marshall · CIK 0001886143 · EVP, Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires 2032-02-10 F2 · derivative.exercise_date: 25% of each option grant will vest on the one-year anniversary of the grant date, with the remainder vesting quarterly thereafter in substantially equal installments over the next 36 months, subject to the employee's continued employment with Calix through the applicable vesting dates. Notwithstanding the foregoing, no shares issued upon exercise of the grant may be transferred in any manner prior to the second anniversary of the date such shares vested. Read SEC document |
| February 10, 2022 Filed Feb 11, 2022 16:17 UTC |
Eleniak Shane Todd MarshallEVP, Products
|
GrantStock Option (right to buy) · Derivative | 116,520 | $0.00 Strike: $36.74 | $0.00 |
DisclosureSEC source: 0001628280-22-002334 · wf-form4_164461424050891.xml · derivative · entry 1 Eleniak Shane Todd Marshall · CIK 0001886143 · EVP, Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,520 Underlying: Common Stock · 116,520 shares Expires 2031-02-11 F1 · derivative.exercise_date: On February 11, 2021, the reporting person was awarded a performance-based nonqualified stock option grant covering 120,000 shares of common stock. On February 10, 2022, the Compensation Committee of Calix, Inc. determined that the performance criteria governing 97.1% of the grant had been achieved, resulting in a nonqualified stock option award of 116,520 shares of common stock for the reporting person. The nonqualified stock option award shall vest: (i) as to 25% of the shares of common stock subject to the stock option award, on February 11, 2022; and (ii) as to the remaining 75% of the shares of common stock subject to the stock option award, quarterly in equal installments over 36 months from February 11, 2022. Read SEC document |
| February 10, 2022 Filed Feb 11, 2022 16:22 UTC |
Weening MichaelPresident & COO
|
GrantStock Option (right to buy) · Derivative | 97,100 | $0.00 Strike: $36.74 | $0.00 |
DisclosureSEC source: 0001628280-22-002339 · wf-form4_164461452702632.xml · derivative · entry 1 Weening Michael · CIK 0001678385 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,100 Underlying: Common Stock · 97,100 shares Expires 2031-02-11 F1 · derivative.exercise_date: On February 11, 2021, the reporting person was awarded a performance-based nonqualified stock option grant covering 100,000 shares of common stock. On February 10, 2022, the Compensation Committee of Calix, Inc. determined that the performance criteria governing 97.1% of the grant had been achieved, resulting in a nonqualified stock option award of 97,100 shares of common stock for the reporting person. The nonqualified stock option award shall vest: (i) as to 25% of the shares of common stock subject to the stock option award, on February 11, 2022; and (ii) as to the remaining 75% of the shares of common stock subject to the stock option award, quarterly in equal installments over 36 months from February 11, 2022. Read SEC document |
| February 10, 2022 Filed Feb 11, 2022 21:19 UTC |
SINDELAR CORYChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 77,680 | $0.00 Strike: $36.74 | $0.00 |
DisclosureSEC source: 0001628280-22-002337 · wf-form4_164461436696182.xml · derivative · entry 1 SINDELAR CORY · CIK 0001226868 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,680 Underlying: Common Stock · 77,680 shares Expires 2031-02-11 F1 · derivative.exercise_date: On February 11, 2021, the reporting person was awarded a performance-based nonqualified stock option grant covering 80,000 shares of common stock. On February 10, 2022, the Compensation Committee of Calix, Inc. determined that the performance criteria governing 97.1% of the grant had been achieved, resulting in a nonqualified stock option award of 77,680 shares of common stock for the reporting person. The nonqualified stock option award shall vest: (i) as to 25% of the shares of common stock subject to the stock option award, on February 11, 2022; and (ii) as to the remaining 75% of the shares of common stock subject to the stock option award, quarterly in equal installments over 36 months from February 11, 2022. Read SEC document |
| February 10, 2022 Filed Feb 11, 2022 21:13 UTC |
Collins John MatthewEVP, Commercial Operations
|
GrantStock Option (right to buy) · Derivative | 125,000 | $0.00 Strike: $55.96 | $0.00 |
DisclosureSEC source: 0001628280-22-002328 · wf-form4_164461401427024.xml · derivative · entry 2 Collins John Matthew · CIK 0001887165 · EVP, Commercial Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires 2032-02-10 F2 · derivative.exercise_date: 25% of each option grant will vest on the one-year anniversary of the grant date, with the remainder vesting quarterly thereafter in substantially equal installments over the next 36 months, subject to the employee's continued employment with Calix through the applicable vesting dates. Notwithstanding the foregoing, no shares issued upon exercise of the grant may be transferred in any manner prior to the second anniversary of the date such shares vested. Read SEC document |
| February 10, 2022 Filed Feb 11, 2022 21:13 UTC |
Collins John MatthewEVP, Commercial Operations
|
GrantStock Option (right to buy) · Derivative | 116,520 | $0.00 Strike: $36.74 | $0.00 |
DisclosureSEC source: 0001628280-22-002328 · wf-form4_164461401427024.xml · derivative · entry 1 Collins John Matthew · CIK 0001887165 · EVP, Commercial Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,520 Underlying: Common Stock · 116,520 shares Expires 2031-02-11 F1 · derivative.exercise_date: On February 11, 2021, the reporting person was awarded a performance-based nonqualified stock option grant covering 120,000 shares of common stock. On February 10, 2022, the Compensation Committee of Calix, Inc. determined that the performance criteria governing 97.1% of the grant had been achieved, resulting in a nonqualified stock option award of 116,520 shares of common stock for the reporting person. The nonqualified stock option award shall vest: (i) as to 25% of the shares of common stock subject to the stock option award, on February 11, 2022; and (ii) as to the remaining 75% of the shares of common stock subject to the stock option award, quarterly in equal installments over 36 months from February 11, 2022. Read SEC document |
| February 04, 2022 Filed Feb 7, 2022 21:24 UTC |
LISTWIN DONALD JDirector
|
PurchaseCommon Stock | 10,000 | $50.94 | $509,400.00 |
DisclosureSEC source: 0001628280-22-001910 · wf-form4_164426906027767.xml · nonDerivative · entry 1 LISTWIN DONALD J · CIK 0001211436 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 310,000 F1 · price: Shares purchased between $50.79 and $50.98 per share at a weighted average price of $50.94. The reporting person will provide full information regarding the number of shares purchased at each purchase price upon request. F2 · balance_after: Shares held by No Mas Ninos, L.P. Mr. Listwin is a general partner of No Mas Ninos, L.P. and may be deemed to have shared voting and investment power over the shares held by the partnership. Mr. Listwin disclaims beneficial ownership of such shares to the extent of his pecuniary interest therein. Read SEC document |
| February 01, 2022 Filed May 18, 2026 22:01 UTC |
Peters Kevin RobertDirector
|
GiftCommon Stock | 126,028 | $0.00 | $0.00 |
DisclosureSEC source: 0001622622-26-000002 · wk-form4_1779141704.xml · nonDerivative · entry 2 Peters Kevin Robert · CIK 0001622622 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By trust Disclosed balance after: 126,028 F1 · ownership.nature: Represents securities held by an irrevocable trust of which the reporting person's spouse is the trustee. The reporting person disclaims beneficial ownership of such securities. Read SEC document |
| February 01, 2022 Filed May 18, 2026 22:01 UTC |
Peters Kevin RobertDirector
|
GiftCommon Stock | 126,028 | $0.00 | $0.00 |
DisclosureSEC source: 0001622622-26-000002 · wk-form4_1779141704.xml · nonDerivative · entry 1 Peters Kevin Robert · CIK 0001622622 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,689 Read SEC document |
| January 18, 2022 Filed Jan 19, 2022 16:06 UTC |
Eleniak Shane Todd MarshallEVP, Products
|
Exercise / conversionStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $5.95 | $0.00 |
DisclosureSEC source: 0001406666-22-000006 · wf-form4_164262636972350.xml · derivative · entry 3 Eleniak Shane Todd Marshall · CIK 0001886143 · EVP, Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires 2027-12-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 100% of the shares subject to the option grant were fully vested and exercisable on January 1, 2021. Read SEC document |
| January 18, 2022 Filed Jan 19, 2022 16:06 UTC |
Eleniak Shane Todd MarshallEVP, Products
|
SaleCommon Stock | 25,000 | $52.77 | $1,319,350.00 |
DisclosureSEC source: 0001406666-22-000006 · wf-form4_164262636972350.xml · nonDerivative · entry 2 Eleniak Shane Todd Marshall · CIK 0001886143 · EVP, Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · price: Shares sold between $52.28 and $53.20 per share at a weighted average price of $52.774. The reporting person will provide full information regarding the number of shares sold at each sale price upon request. Read SEC document |
| January 18, 2022 Filed Jan 19, 2022 16:06 UTC |
Eleniak Shane Todd MarshallEVP, Products
|
Exercise / conversionCommon Stock | 25,000 | $5.95 | $148,750.00 |
DisclosureSEC source: 0001406666-22-000006 · wf-form4_164262636972350.xml · nonDerivative · entry 1 Eleniak Shane Todd Marshall · CIK 0001886143 · EVP, Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| December 15, 2021 Filed Dec 16, 2021 16:59 UTC |
Eleniak Shane Todd MarshallEVP, Products
|
Exercise / conversionStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $5.95 | $0.00 |
DisclosureSEC source: 0001406666-21-000142 · wf-form4_163969193542170.xml · derivative · entry 3 Eleniak Shane Todd Marshall · CIK 0001886143 · EVP, Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2027-12-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 100% of the shares subject to the option grant were fully vested and exercisable on January 1, 2021. Read SEC document |
| December 15, 2021 Filed Dec 16, 2021 16:59 UTC |
Eleniak Shane Todd MarshallEVP, Products
|
SaleCommon Stock | 25,000 | $64.72 | $1,618,000.00 |
DisclosureSEC source: 0001406666-21-000142 · wf-form4_163969193542170.xml · nonDerivative · entry 2 Eleniak Shane Todd Marshall · CIK 0001886143 · EVP, Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · price: Shares sold between $63.26 and $65.88 per share at a weighted average price of $64.72. The reporting person will provide full information regarding the number of shares sold at each sale price upon request. Read SEC document |
| December 15, 2021 Filed Dec 16, 2021 16:59 UTC |
Eleniak Shane Todd MarshallEVP, Products
|
Exercise / conversionCommon Stock | 25,000 | $5.95 | $148,750.00 |
DisclosureSEC source: 0001406666-21-000142 · wf-form4_163969193542170.xml · nonDerivative · entry 1 Eleniak Shane Todd Marshall · CIK 0001886143 · EVP, Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan Read SEC document |
| November 27, 2021 Filed Nov 29, 2021 16:10 UTC |
Weening MichaelPresident & COO
|
GrantCommon Stock · Derivative | 120,000 | $0.00 Strike: $68.04 | $0.00 |
DisclosureSEC source: 0001406666-21-000140 · wf-form4_163822021314771.xml · derivative · entry 2 Weening Michael · CIK 0001678385 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,000 Underlying: Common Stock · 120,000 shares Expires 2031-11-27 F1 · derivative.exercise_date: 25% of the shares subject to the stock option grant will vest on November 27, 2022, with the remainder vesting quarterly thereafter in substantially equal installments over the next 36 months, subject to thereporting person's continued employment with Calix through the applicable vesting dates. Read SEC document |
| November 27, 2021 Filed Nov 29, 2021 21:09 UTC |
SINDELAR CORYChief Financial Officer
|
GrantCommon Stock · Derivative | 100,000 | $0.00 Strike: $68.04 | $0.00 |
DisclosureSEC source: 0001406666-21-000138 · wf-form4_163822015218764.xml · derivative · entry 2 SINDELAR CORY · CIK 0001226868 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2031-11-27 F1 · derivative.exercise_date: 25% of the shares subject to the stock option grant will vest on November 27, 2022, with the remainder vesting quarterly thereafter in substantially equal installments over the next 36 months, subject to thereporting person's continued employment with Calix through the applicable vesting dates. Read SEC document |
| November 15, 2021 Filed Nov 16, 2021 16:19 UTC |
Eleniak Shane Todd MarshallEVP, Products
|
Exercise / conversionStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $5.95 | $0.00 |
DisclosureSEC source: 0001406666-21-000136 · wf-form4_163709736945894.xml · derivative · entry 3 Eleniak Shane Todd Marshall · CIK 0001886143 · EVP, Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 25,000 shares Expires 2027-12-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 100% of the shares subject to the option grant were fully vested and exercisable on January 1, 2021. Read SEC document |
| November 15, 2021 Filed Nov 16, 2021 16:19 UTC |
Eleniak Shane Todd MarshallEVP, Products
|
SaleCommon Stock | 25,000 | $72.52 | $1,813,000.00 |
DisclosureSEC source: 0001406666-21-000136 · wf-form4_163709736945894.xml · nonDerivative · entry 2 Eleniak Shane Todd Marshall · CIK 0001886143 · EVP, Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · price: Shares sold between $70.37 and $74.75 per share at a weighted average price of $72.52. The reporting person will provide full information regarding the number of shares sold at each sale price upon request. Read SEC document |
| November 15, 2021 Filed Nov 16, 2021 16:19 UTC |
Eleniak Shane Todd MarshallEVP, Products
|
Exercise / conversionCommon Stock | 25,000 | $5.95 | $148,750.00 |
DisclosureSEC source: 0001406666-21-000136 · wf-form4_163709736945894.xml · nonDerivative · entry 1 Eleniak Shane Todd Marshall · CIK 0001886143 · EVP, Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| November 08, 2021 Filed Nov 9, 2021 21:12 UTC |
LISTWIN DONALD JDirector
|
GiftCommon Stock | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001406666-21-000134 · wf-form4_163649235200237.xml · nonDerivative · entry 1 LISTWIN DONALD J · CIK 0001211436 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 785,000 F1 · kind: Represents a bona fide gift by reporting person. Read SEC document |
| November 04, 2021 Filed Nov 4, 2021 20:07 UTC |
LISTWIN DONALD JDirector
|
PurchaseCommon Stock | 23 | $74.36 | $1,710.17 |
DisclosureSEC source: 0001406666-21-000132 · wf-form4_163605638969810.xml · nonDerivative · entry 1 LISTWIN DONALD J · CIK 0001211436 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 800,000 Read SEC document |
| November 02, 2021 Filed Nov 2, 2021 21:09 UTC |
Collins John MatthewEVP, Commercial Operations
|
SaleCommon Stock | 829 | $70.05 | $58,072.44 |
DisclosureSEC source: 0001406666-21-000128 · wf-form4_163588735323756.xml · nonDerivative · entry 4 Collins John Matthew · CIK 0001887165 · EVP, Commercial Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F3 · price: Shares sold between $67.75 and $72.37 per share at a weighted average price of $70.0512. The reporting person will provide full information regarding the number of shares sold at each sale price upon request. Read SEC document |
| November 02, 2021 Filed Nov 3, 2021 20:56 UTC |
DENUCCIO KEVIN ADirector
|
SaleCommon Stock | 5,178 | $68.97 | $357,126.66 |
DisclosureSEC source: 0001406666-21-000130 · wf-form4_163597296717751.xml · nonDerivative · entry 3 DENUCCIO KEVIN A · CIK 0001227891 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,477 Read SEC document |
| November 02, 2021 Filed Nov 3, 2021 20:56 UTC |
DENUCCIO KEVIN ADirector
|
SaleCommon Stock | 9,310 | $69.00 | $642,390.00 |
DisclosureSEC source: 0001406666-21-000130 · wf-form4_163597296717751.xml · nonDerivative · entry 2 DENUCCIO KEVIN A · CIK 0001227891 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,655 Read SEC document |
| November 02, 2021 Filed Nov 3, 2021 20:56 UTC |
DENUCCIO KEVIN ADirector
|
SaleCommon Stock | 5,612 | $68.82 | $386,243.09 |
DisclosureSEC source: 0001406666-21-000130 · wf-form4_163597296717751.xml · nonDerivative · entry 1 DENUCCIO KEVIN A · CIK 0001227891 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,965 F1 · price: Shares sold between $68.79 and $68.911 per share at a weighted average price of $68.8245. The reporting person will provide full information regarding the number of shares sold at each sale price upon request. Read SEC document |
| October 29, 2021 Filed Nov 2, 2021 21:09 UTC |
Collins John MatthewEVP, Commercial Operations
|
Exercise / conversionStock Option (right to buy) · Derivative | 10,829 | $0.00 Strike: $6.95 | $0.00 |
DisclosureSEC source: 0001406666-21-000128 · wf-form4_163588735323756.xml · derivative · entry 5 Collins John Matthew · CIK 0001887165 · EVP, Commercial Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,171 Underlying: Common Stock · 10,829 shares Expires 2027-08-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: 100% of the shares subject to the option grant were fully vested and exercisable on August 1, 2021. Read SEC document |
| October 29, 2021 Filed Nov 2, 2021 21:09 UTC |
Collins John MatthewEVP, Commercial Operations
|
SaleCommon Stock | 1,088 | $61.60 | $67,020.91 |
DisclosureSEC source: 0001406666-21-000128 · wf-form4_163588735323756.xml · nonDerivative · entry 3 Collins John Matthew · CIK 0001887165 · EVP, Commercial Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 829 F2 · price: Shares sold between $61.50 and $61.775 per share at a weighted average price of $61.6001. The reporting person will provide full information regarding the number of shares sold at each sale price upon request. Read SEC document |
| October 29, 2021 Filed Nov 2, 2021 21:09 UTC |
Collins John MatthewEVP, Commercial Operations
|
SaleCommon Stock | 8,912 | $61.79 | $550,692.98 |
DisclosureSEC source: 0001406666-21-000128 · wf-form4_163588735323756.xml · nonDerivative · entry 2 Collins John Matthew · CIK 0001887165 · EVP, Commercial Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,917 F1 · price: Shares sold between $61.35 and $62.485 per share at a weighted average price of $61.7923. The reporting person will provide full information regarding the number of shares sold at each sale price upon request. Read SEC document |
| October 29, 2021 Filed Nov 2, 2021 21:09 UTC |
Collins John MatthewEVP, Commercial Operations
|
Exercise / conversionCommon Stock | 10,829 | $6.95 | $75,261.55 |
DisclosureSEC source: 0001406666-21-000128 · wf-form4_163588735323756.xml · nonDerivative · entry 1 Collins John Matthew · CIK 0001887165 · EVP, Commercial Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,829 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 28, 2021 Filed Oct 29, 2021 20:36 UTC |
PLANTS J DANIELDirector
|
SaleCommon Stock | 115,000 | $60.12 | $6,914,306.00 |
DisclosureSEC source: 0001406666-21-000122 · wf-form4_163553977026087.xml · nonDerivative · entry 1 PLANTS J DANIEL · CIK 0001626681 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Owned by Voce Capital Management LLC Disclosed balance after: 117,865 F1 · ownership.nature: Shares held by Voce Capital Management LLC. Mr. Plants is managing member of Voce Capital Management LLC and disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein. Read SEC document |
| October 28, 2021 Filed Nov 1, 2021 20:11 UTC |
SINDELAR CORYChief Financial Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $5.05 | $0.00 |
DisclosureSEC source: 0001406666-21-000126 · wf-form4_163579749418761.xml · derivative · entry 3 SINDELAR CORY · CIK 0001226868 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 280,000 Underlying: Common Stock · 20,000 shares Expires 2027-10-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 100% of the shares subject to the option grant were fully vested and exercisable on October 1, 2021. Read SEC document |
| October 28, 2021 Filed Nov 1, 2021 20:11 UTC |
SINDELAR CORYChief Financial Officer
|
SaleCommon Stock | 20,000 | $60.05 | $1,200,926.00 |
DisclosureSEC source: 0001406666-21-000126 · wf-form4_163579749418761.xml · nonDerivative · entry 2 SINDELAR CORY · CIK 0001226868 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,310 F1 · price: Shares sold between $60.00 and $60.295 per share at a weighted average price of $60.0463. The reporting person will provide full information regarding the number of shares sold at each sale price upon request. Read SEC document |
| October 28, 2021 Filed Nov 1, 2021 20:11 UTC |
SINDELAR CORYChief Financial Officer
|
Exercise / conversionCommon Stock | 20,000 | $5.05 | $101,000.00 |
DisclosureSEC source: 0001406666-21-000126 · wf-form4_163579749418761.xml · nonDerivative · entry 1 SINDELAR CORY · CIK 0001226868 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,310 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 28, 2021 Filed Nov 1, 2021 20:06 UTC |
LISTWIN DONALD JDirector
|
PurchaseCommon Stock | 15,000 | $60.00 | $899,992.50 |
DisclosureSEC source: 0001406666-21-000124 · wf-form4_163579717776921.xml · nonDerivative · entry 1 LISTWIN DONALD J · CIK 0001211436 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 799,977 F1 · price: Shares purchased between $59.978 and $60.00 per share at a weighted average price of $59.9995. The reporting person will provide full information regarding the number of shares purchased at each purchase price upon request. Read SEC document |
| October 15, 2021 Filed Oct 18, 2021 16:30 UTC |
Eleniak Shane Todd MarshallEVP, Products
|
Exercise / conversionStock Option (right to buy) · Derivative | 25,000 | $5.95 Strike: $5.95 | $148,750.00 |
DisclosureSEC source: 0001406666-21-000112 · wf-form4_163458901628032.xml · derivative · entry 3 Eleniak Shane Todd Marshall · CIK 0001886143 · EVP, Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 25,000 shares Expires 2027-12-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · derivative.exercise_date: 100% of the shares subject to the option grant were fully vested and exercisable on January 1, 2021. Read SEC document |
| October 15, 2021 Filed Oct 18, 2021 16:30 UTC |
Eleniak Shane Todd MarshallEVP, Products
|
SaleCommon Stock | 25,000 | $58.61 | $1,465,125.00 |
DisclosureSEC source: 0001406666-21-000112 · wf-form4_163458901628032.xml · nonDerivative · entry 2 Eleniak Shane Todd Marshall · CIK 0001886143 · EVP, Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: Shares sold between $57.52 and $60.00 per share at a weighted average price of $58.605. The reporting person will provide full information regarding the number of shares sold at each sale price upon request. Read SEC document |
| October 15, 2021 Filed Oct 18, 2021 16:30 UTC |
Eleniak Shane Todd MarshallEVP, Products
|
Exercise / conversionCommon Stock | 25,000 | $5.95 | $148,750.00 |
DisclosureSEC source: 0001406666-21-000112 · wf-form4_163458901628032.xml · nonDerivative · entry 1 Eleniak Shane Todd Marshall · CIK 0001886143 · EVP, Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| September 30, 2021 Filed Oct 4, 2021 19:42 UTC |
Eleniak Shane Todd MarshallEVP, Products
|
Exercise / conversionStock Option (right to buy) · Derivative | 26,000 | $0.00 Strike: $5.95 | $0.00 |
DisclosureSEC source: 0001406666-21-000108 · wf-form4_163339095692321.xml · derivative · entry 3 Eleniak Shane Todd Marshall · CIK 0001886143 · EVP, Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 26,000 shares Expires 2027-12-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · derivative.exercise_date: 100% of the shares subject to the option grant were fully vested and exercisable on January 1, 2021. Read SEC document |
| September 30, 2021 Filed Oct 4, 2021 19:42 UTC |
Eleniak Shane Todd MarshallEVP, Products
|
SaleCommon Stock | 26,000 | $48.50 | $1,261,000.00 |
DisclosureSEC source: 0001406666-21-000108 · wf-form4_163339095692321.xml · nonDerivative · entry 2 Eleniak Shane Todd Marshall · CIK 0001886143 · EVP, Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| September 30, 2021 Filed Oct 4, 2021 19:42 UTC |
Eleniak Shane Todd MarshallEVP, Products
|
Exercise / conversionCommon Stock | 26,000 | $5.95 | $154,700.00 |
DisclosureSEC source: 0001406666-21-000108 · wf-form4_163339095692321.xml · nonDerivative · entry 1 Eleniak Shane Todd Marshall · CIK 0001886143 · EVP, Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| August 14, 2021 Filed Aug 16, 2021 17:29 UTC |
Weening MichaelPresident & COO
|
PurchaseCommon Stock | 337 | $31.28 | $10,541.36 |
DisclosureSEC source: 0001406666-21-000102 · wf-form4_162914935559792.xml · nonDerivative · entry 1 Weening Michael · CIK 0001678385 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,922 F1 · shares: The reporting person is voluntarily reporting the acquisition of shares of the issuer's common stock pursuant to the Calix, Inc. Amended and Restated Employee Stock Purchase Plan ("ESPP") for the ESPP purchase period of February 15, 2021 through August 14, 2021. This transaction is exempt under Rule 16b-3(c). F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on February 15, 2021, the first trading day of the purchase period. Read SEC document |
| August 14, 2021 Filed Aug 17, 2021 17:51 UTC Amendment |
Weening MichaelPresident & COO
|
GrantCommon Stock | 337 | $31.28 | $10,541.36 |
DisclosureSEC source: 0001406666-21-000104 · wf-form4a_162923703159086.xml · nonDerivative · entry 1 Weening Michael · CIK 0001678385 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,922 F1 · kind: Amended to correct an administrative error relating to the transaction code on the original Form 4 filed on August 16, 2021. F2 · shares: The reporting person is voluntarily reporting the acquisition of shares of the issuer's common stock pursuant to the Calix, Inc. Amended and Restated Employee Stock Purchase Plan ("ESPP") for the ESPP purchase period of February 15, 2021 through August 14, 2021. This transaction is exempt under Rule 16b-3(c). F3 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on February 15, 2021, the first trading day of the purchase period. Read SEC document |
| August 06, 2021 Filed Aug 9, 2021 20:07 UTC |
BOWICK CHRISTOPHER JDirector
|
SaleCommon Stock | 20,000 | $45.41 | $908,234.00 |
DisclosureSEC source: 0001406666-21-000090 · wf-form4_162853964383337.xml · nonDerivative · entry 1 BOWICK CHRISTOPHER J · CIK 0001198471 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,927 F1 · price: Shares sold between $45.00 and $45.88 per share at a weighted average price of $45.4117. The reporting person will provide full information regarding the number of shares sold at each sale price upon request. Read SEC document |
| August 06, 2021 Filed Aug 9, 2021 20:13 UTC |
PLANTS J DANIELDirector
|
SaleCommon Stock | 100,000 | $45.41 | $4,541,470.00 |
DisclosureSEC source: 0001406666-21-000094 · wf-form4_162853999647653.xml · nonDerivative · entry 1 PLANTS J DANIEL · CIK 0001626681 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Owned by Voce Capital Management LLC Disclosed balance after: 232,865 F1 · ownership.nature: Shares held by Voce Capital Management LLC. Mr. Plants is managing member of Voce Capital Management LLC and disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein. Read SEC document |
| August 05, 2021 Filed Aug 9, 2021 20:09 UTC |
Matthews MichaelDirector
|
SaleCommon Stock | 885 | $45.07 | $39,882.61 |
DisclosureSEC source: 0001406666-21-000092 · wf-form4_162853975266850.xml · nonDerivative · entry 2 Matthews Michael · CIK 0001507710 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,000 Read SEC document |
| August 05, 2021 Filed Aug 9, 2021 20:09 UTC |
Matthews MichaelDirector
|
SaleCommon Stock | 2,500 | $44.73 | $111,836.50 |
DisclosureSEC source: 0001406666-21-000092 · wf-form4_162853975266850.xml · nonDerivative · entry 1 Matthews Michael · CIK 0001507710 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,885 F1 · price: Shares sold between $44.64 and $44.86 per share at a weighted average price of $44.7346. The reporting person will provide full information regarding the number of shares sold at each sale price upon request. Read SEC document |
| August 04, 2021 Filed Aug 6, 2021 22:57 UTC |
PLANTS J DANIELDirector
|
SaleCommon Stock | 1,290 | $45.97 | $59,297.95 |
DisclosureSEC source: 0001406666-21-000088 · wf-form4_162829062032621.xml · nonDerivative · entry 1 PLANTS J DANIEL · CIK 0001626681 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Owned by Voce Capital Management LLC Disclosed balance after: 332,865 F1 · ownership.nature: Shares held by Voce Capital Management LLC. Mr. Plants is managing member of Voce Capital Management LLC and disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.